A new design with no moving parts converts heat to electricity more efficiently than a steam turbine and could lead to a fully decarbonized power grid.
Engineers at MIT and the National Renewable Energy Laboratory (NREL) have designed a heat engine with no moving parts. It converts heat to electricity with over 40% efficiency—making it more efficient than steam turbines, the industrial standard.
The invention is a thermophotovoltaic (TPV) cell, similar to a solar panel’s photovoltaic cells, that passively captures high-energy photons from a white-hot heat source. It can generate electricity from sources that reach 1,900 to 2,400 °C—too hot for turbines, with their moving parts. The previous record efficiency for a TPV cell was 32%, but the team improved this performance by using materials that are able to convert higher-temperature, higher-energy photons.
The researchers plan to incorporate the TPV cells into a grid-scale thermal battery. The system would absorb excess energy from renewable sources such as the sun and store that energy in heavily insulated banks of hot graphite. Cells would convert the heat into electricity and dispatch it to a power grid when needed.
The researchers have now successfully demonstrated the main parts of the system in small-scale experiments; the experimental TPV cells are about a centimeter square. They are working to integrate the parts to demonstrate a fully operational system. From there, they hope to scale up the system to replace fossil-fuel plants on the power grid. Coauthor Asegun Henry, a professor of mechanical engineering, envisions TPV cells about 10,000 feet square and operating in climate-controlled warehouses to draw power from huge banks of stored solar energy.
“Thermophotovoltaic cells were the last key step toward demonstrating that thermal batteries are a viable concept,” Henry says. “The technology is safe, environmentally benign in its life cycle, and can have a tremendous impact on abating carbon dioxide emissions from electricity production.”
This story was part of our July/August 2022 issue.
The city wants to get right what Sidewalk Labs got so wrong.
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Discover special offers, top stories, upcoming events, and more.
Thank you for submitting your email!
It looks like something went wrong.
We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.
Our in-depth reporting reveals what’s going on now to prepare you for what’s coming next.
Subscribe to support our journalism.